Clinical Trials Browser

Phase EARLY_PHASE1 × Thalidomide × Plasma cell × Clear all

NCT01537861 2015-01-26

Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma

Phase EARLY_PHASE1 Terminated

Multiple Myeloma